You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 13, 2024

~ Buy the CLEVIPREX (clevidipine) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR CLEVIPREX


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Cleviprex

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00666328 ↗ Clevidipine in the Treatment of Patients With Acute Hypertension and Intracerebral Hemorrhage (ACCELERATE) Completed The Medicines Company Phase 3 2008-06-01 The purpose of this study was to determine the efficacy and safety of clevidipine for treating acute hypertension (high blood pressure, defined as systolic blood pressure >160 mmHg) in patients with intracerebral hemorrhage (i.e., bleeding in the brain; stroke).
NCT00799604 ↗ Clevidipine Bolus Administration in the Treatment of Hypertensive Patients Undergoing Cardiac Surgery (SPRINT) Completed The Medicines Company Phase 2 2008-11-01 This study was designed to evaluate the pharmacodynamics of a bolus dosing regimen of clevidipine, a vascular-selective L-type calcium channel antagonist, for the management of blood pressure in cardiac surgery patients, as well as to evaluate the efficacy, safety and pharmacokinetics of clevidipine after bolus administration.
NCT00803634 ↗ Clevidipine in the Treatment of Blood Pressure in Patients With Acute Heart Failure (PRONTO) Completed The Medicines Company Phase 3 2008-12-01 The purpose of this study was to evaluate the efficacy and safety of intravenous (IV) clevidipine as compared with standard of care IV antihypertensive agents for blood pressure (BP) lowering in patients with acute heart failure and elevated BP.
NCT00952081 ↗ A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients Completed The Medicines Company Phase 4 2009-07-01 This protocol describes a study to gain experience in the use of Clevidipine for perioperative blood pressure control in patients undergoing craniotomy for brain tumor or epilepsy focus resection. The purpose of this study is to establish the efficacy of Clevidipine for intraoperative blood pressure control in patients undergoing intracranial procedures, and gather information on the dosage and adverse effects of Clevidipine in neurosurgical patients. This initial pilot experience serves to familiarize the investigators with the use of this drug prior to initiating a planned randomized trial versus institutional standard-of-care therapy. The investigators will obtain greater familiarity with the dosing of clevidipine in this patient population and collect information on the incidence of adverse effects.
NCT00952081 ↗ A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients Completed New York University School of Medicine Phase 4 2009-07-01 This protocol describes a study to gain experience in the use of Clevidipine for perioperative blood pressure control in patients undergoing craniotomy for brain tumor or epilepsy focus resection. The purpose of this study is to establish the efficacy of Clevidipine for intraoperative blood pressure control in patients undergoing intracranial procedures, and gather information on the dosage and adverse effects of Clevidipine in neurosurgical patients. This initial pilot experience serves to familiarize the investigators with the use of this drug prior to initiating a planned randomized trial versus institutional standard-of-care therapy. The investigators will obtain greater familiarity with the dosing of clevidipine in this patient population and collect information on the incidence of adverse effects.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Cleviprex

Condition Name

Condition Name for Cleviprex
Intervention Trials
Hypertension 8
Subarachnoid Hemorrhage 3
Dyspnea 1
Vascular Diseases 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Cleviprex
Intervention Trials
Hypertension 7
Hemorrhage 5
Subarachnoid Hemorrhage 3
Heart Failure 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Cleviprex

Trials by Country

Trials by Country for Cleviprex
Location Trials
United States 36
Germany 3
France 1
Switzerland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Cleviprex
Location Trials
Ohio 4
New York 4
North Carolina 4
California 3
Michigan 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Cleviprex

Clinical Trial Phase

Clinical Trial Phase for Cleviprex
Clinical Trial Phase Trials
Phase 4 5
Phase 3 4
Phase 2 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Cleviprex
Clinical Trial Phase Trials
Withdrawn 5
Completed 4
Unknown status 2
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Cleviprex

Sponsor Name

Sponsor Name for Cleviprex
Sponsor Trials
The Medicines Company 10
Henry Ford Health System 2
Chiesi Farmaceutici S.p.A. 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Cleviprex
Sponsor Trials
Industry 12
Other 9
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.